Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III

被引:12
|
作者
Kern, David M. [1 ]
Balu, Sanjeev [2 ]
Tunceli, Ozgur [1 ]
Anzalone, Deborah [2 ]
机构
[1] HealthCore Inc, Wilmington, DE 19801 USA
[2] AstraZeneca Pharmaceut LP, Wilmington, DE USA
关键词
Adherence; Coronary heart disease; Dyslipidemia; Retrospective; Statins; MEDICATIONS; GUIDELINES; UPDATE;
D O I
10.1185/03007995.2014.971151
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare clinical characteristics, statin treatment patterns and adherence among patients at different risk for coronary heart disease (CHD) as defined by National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III guidelines. Methods: Patients >= 18 years old with >= 1 claim for dyslipidemia, >= 1 statin claim, or >= 1 LDL-C value >= 100 mg/dL were identified from 1 January 2007 to 31 July 2012. Patients were classified as low risk (LR) (0-1 risk factor: hypertension, age >= 45 years [men] or >= 55 years [women], or low HDL-C), moderate/moderately high risk (MR) (>= 2 risk factors), high risk (HR) (CHD or CHD risk equivalent), or very high risk (VHR) (acute coronary syndrome, or established cardiovascular disease plus diabetes or metabolic syndrome). Medication use and lipid levels during the 12 months before and statin use during the 6 months after index were compared across risk groups. Results: There were 1,524,351 LR, 242,357 MR, 188,222 HR, and 57,469 VHR patients identified. Statin use was observed in 15% of all patients, but was higher in the VHR group (45%) versus LR (12%), MR (18%), and HR (29%) groups. Simvastatin accounted for 50%-52% of all statin use, and average statin dose was higher among VHR patients compared with all other groups. Adherence was low overall (mean proportion of days covered [PDC]: 0.57), but higher among VHR (0.69) versus others (mean PDC: 0.55, 0.59, and 0.59 in LR, MR, and HR groups, respectively). Conclusions: Statin treatment was low across all risk groups, and VHR patients had higher doses and better adherence compared with other risk groups. However, adherence was not optimal, indicating a potential limited benefit from statin treatment.
引用
收藏
页码:2443 / 2451
页数:9
相关论文
共 50 条
  • [31] A Message from the Laboratory Community to the National Cholesterol Education Program Adult Treatment Panel IV
    Vesper, Hubert W.
    Wilson, Peter W. F.
    Rifai, Nader
    CLINICAL CHEMISTRY, 2012, 58 (03) : 523 - 527
  • [32] Treatment of high risk patients with ezetimibe plus simvastatin coadministration versus simvastatin alone to attain national cholesterol education program adult treatment panel III low-density lipoprotein cholesterol goals
    Feldman, T
    Koren, M
    Insull, W
    McKenney, J
    Schrott, H
    Lwein, A
    Shah, S
    Sidisin, M
    Cho, M
    Kush, D
    Mitchel, Y
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 118 - 118
  • [33] The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile
    Blackburn, Patricia
    Lemieux, Isabelle
    Almeras, Natalie
    Bergeron, Jean
    Cote, Melanie
    Tremblay, Angelo
    Lamarche, Benoit
    Despres, Jean-Pierre
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (08): : 1123 - 1130
  • [34] Disparity between non-HDL goal attainment and National Cholesterol Education Program Adult Treatment Panel III recommendations
    Alexander, C
    Kamal-Bahl, SJ
    Nag, S
    Cziraky, MJ
    Willey, VJ
    Foley, K
    Daniel, GW
    Sajjan, S
    Bullano, MF
    CIRCULATION, 2004, 109 (20) : E272 - E272
  • [35] Metabolic Syndrome and Cardiac Disease in Japanese Men: Applicability of the Concept of Metabolic Syndrome Defined by the National Cholesterol Education Program–Adult Treatment Panel III to Japanese Men—The Tanno and Sobetsu Study
    Hiroshi Takeuchi
    Shigeyuki Saitoh
    Satoru Takagi
    Hirofumi Ohnishi
    Junichi Ohhata
    Takeshi Isobe
    Kazuaki Shimamoto
    Hypertension Research, 2005, 28 : 203 - 208
  • [36] National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease?
    Rezaianzadeh, Abbas
    Namayandeh, Seyedeh-Mahdieh
    Sadr, Seyed-Mahmood
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2012, 3 (08) : 552 - 558
  • [37] THE NATIONAL CHOLESTEROL EDUCATION-PROGRAM - IMPLICATIONS FOR DIETETIC PRACTITIONERS FROM THE ADULT TREATMENT PANEL RECOMMENDATIONS
    ERNST, ND
    CLEEMAN, J
    MULLIS, R
    SOOTERBOCHENEK, J
    VANHORN, L
    JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1988, 88 (11) : 1401 - &
  • [38] Evaluating the Efficacy of an Education and Treatment Program for Patients with Coronary Heart Disease
    Melamed, Richard J.
    Tillmann, Alexander
    Kufleitner, Heidrun-Eva
    Thuermer, Uwe
    Duersch, Martin
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2014, 111 (47):
  • [39] Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome
    Carr, DB
    Utzschneider, KM
    Hull, RL
    Kodama, K
    Retzlaff, BM
    Brunzell, JD
    Shofer, JB
    Fish, BE
    Knopp, RH
    Kahn, SE
    DIABETES, 2004, 53 (08) : 2087 - 2094
  • [40] National cholesterol education program, adult treatment panel III (NCEP-ATPIII) criteria for the metabolic syndrome (MS) are unreliable in children
    Garcia, MH
    Nussbaum, H
    Grant, R
    Dimartino-Nardi, J
    DIABETES, 2004, 53 : A68 - A68